Clinical Trial Update: Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access [Phase 1, Phase 2]

View source ↗

Summary

This update reports interim results from Phase 1/2 trials evaluating buprenorphine, combined with technology-enabled access to care, to address delays in treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont Medical Center | Conditions: Opioid-related Disorders | Phase 1, Phase 2 | Status: COMPLETED